Application of a feasible method for determination of biofilm antimicrobial susceptibility in staphylococci

APMIS

Volumn 118, Issue 11, 2010, Pages 873-877

  Antunes, Ana Lúcia Souza ^a   Trentin, Danielle Silva ^a   Bonfanti, Jéssica Weis ^a   Pinto, Camille Cattani Ferreira ^a   Perez, Leandro Reus Rodrigues ^a   Macedo, Alexandre José ^a   Barth, Afonso Luis ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Biofilm antimicrobial susceptibility method; Biofilm eradication; Staphylococcal biofilms; Staphylococcal infections; Vancomycin

Indexed keywords

VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BIOFILM; CONTROLLED STUDY; DRUG CONCENTRATION; FEASIBILITY STUDY; IN VITRO STUDY; INTERMETHOD COMPARISON; MINIMAL BIOFILM ERADICATION CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS UREOLYTICUS; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHYSIOLOGY; REPRODUCIBILITY; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BIOFILMS; HUMANS; MICROBIAL SENSITIVITY TESTS; REPRODUCIBILITY OF RESULTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN;

EID: 78149240715     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02681.x     Document Type: Article

References (14)

1. Fitzpatrick F, Humphreys H, O'Gara JP. The genetics of staphylococcal biofilm formation - will a greater understanding of pathogenesis lead to better management of device-related infection? Clin Microbiol Infect 2005;11:967-73.
2. Söderquist B. Surgical site infections in cardiac surgery: microbiology. APMIS 2007;115:1008-11.
3. Stepanovic S, Vukovic D, Hola V, Bonaventura G, Djukic S, Cirkovic I, et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by Staphylococci. APMIS 2007;115:891-9.
4. Frank KL, Patel R. Activity of sodium metabisulfite against planktonic and biofilm Staphylococcus species. Diagn Microbiol Infect Disease 2007;57:355-9.
5. Werthén M, Henriksson L, Jensen PØ, Sternberg C, Givskov M, Bjarnsholt T. An in vitro model of bacterial infections in wounds and other soft tissues. APMIS 2010;118:156-64.
6. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999;37:1771-6.
7. Moskowitz SM, Foster JM, Emerson J, Burns JL. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 2004;42:1915-22.
8. Frank KL, Reichert EJ, Piper KE, Patel R. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob Agents Chemother 2007;51:888-95.
9. Antunes ALS, Secchi C, Reiter KC, Perez LRR, Freitas ALP, D'Azevedo PA. Feasible identification of Staphylococcus epidermidis using desferrioxamine and fosfomycin disks. APMIS 2008;116:16-20.
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. Wayne, PA: CLSI, 2009.
11. Patel R. Biofilms and antimicrobial resistance. Clin Orthop Relat Res 2005;437:41-7.
12. International Conference on Harmonization - ICH. Harmonized Tripartite Guideline, Text on Validation of Analytical Procedures, Q2B. Silver Spring, MD: International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals, 2005.
13. Presterl E, Hadju S, Lassnigg AM, Hirschl AM, Holinka J, Graninger W. Effects of azytromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2009;53:3205-10.
14. El-Azizi M, Rao S, Kanchanapoon T, Khardori N. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against and disrupted biofilms of staphylococci. Ann Clin Microbiol Antimicrob 2005;4:1-9.